Pseudomonas aeruginosa persister cell formation upon antibiotic exposure in planktonic and biofilm state

Sci Rep. 2022 Sep 27;12(1):16151. doi: 10.1038/s41598-022-20323-3.

Abstract

Persister cell (PC) is dormant, tolerant to antibiotics, and a transient reversible phenotype. These phenotypes are observed in P. aeruginosa and cause bacterial chronic infection as well as recurrence of biofilm-mediated infection. PC formation requires stringent response and toxin-antitoxin (TA) modules. This study shows the P. aeruginosa PC formation in planktonic and biofilm stages on ceftazidime, gentamicin, and ciprofloxacin treatments. The PC formation was studied using persister assay, flow cytometry using Redox Sensor Green, fluorescence as well as Confocal Laser Scanning Microscopy, and gene expression of stringent response and TA genes. In the planktonic stage, ceftazidime showed a high survival fraction, high redox activity, and elongation of cells was observed followed by ciprofloxacin and gentamicin treatment having redox activity and rod-shaped cells. The gene expression of stringent response and TA genes were upregulated on gentamicin followed by ceftazidime treatment and varied among the isolates. In the biofilm stage, gentamicin and ciprofloxacin showed the biphasic killing pattern, redox activity, gene expression level of stringent response and TA varied across the isolates. Ceftazidime treatment showed higher persister cells in planktonic growth while all three antibiotics were able to induce persister cell formation in the biofilm stage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Antitoxins* / metabolism
  • Bacterial Infections*
  • Biofilms
  • Ceftazidime / pharmacology
  • Ciprofloxacin / metabolism
  • Ciprofloxacin / pharmacology
  • Gentamicins / metabolism
  • Gentamicins / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Plankton
  • Pseudomonas aeruginosa

Substances

  • Anti-Bacterial Agents
  • Antitoxins
  • Gentamicins
  • Ciprofloxacin
  • Ceftazidime